STOCK TITAN

Shoulder Innovations ownership: USVP, PMG XII and Tansey at 13.3%

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Shoulder Innovations, Inc. received a Schedule 13G reporting significant beneficial ownership by entities affiliated with U.S. Venture Partners and Casey M. Tansey as of the event date 09/30/2025.

U.S. Venture Partners XII, L.P. reports beneficial ownership of 1,686,403 shares of common stock, representing 8.2%, with shared voting and dispositive power over those shares. Presidio Management Group XII, L.L.C. reports 2,693,121 shares (13.1%) with shared voting and dispositive power. Casey M. Tansey reports an aggregate 2,740,787 shares (13.3%), including 47,666 shares with sole voting and dispositive power and 2,693,121 shares with shared power.

Percentages are based on 20,601,684 shares outstanding as of November 5, 2025, as reported by the company in its Form 10-Q filed November 12, 2025.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The reported securities are owned directly by U.S. Venture Partners XII, L.P. ("USVP XII"). Presidio Management Group XII, L.L.C. ("PMG XII") is the general partner of each of the USVP XII Funds (as defined below) and may be deemed to have sole voting and dispositive power over the reported securities held by the USVP XII Funds. Dr. Jonathan Root, a member of the Issuer's board of directors, Steven Krausz, Richard Lewis and Dafina Toncheva are the managing members of PMG XII, who may be deemed to share voting and dispositive power over the shares held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein. The amount beneficially owned by each Reporting Person is determined based on 20,601,684 shares of Common Stock outstanding as of November 5, 2025 as reported by the Issuer in its Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission (the "Commission") on November 12, 2025 (the "Form 10-Q").


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of (i) 1,686,403 shares of Common Stock held directly by USVP XII, (ii) 85,587 shares of Common Stock held directly by U.S. Venture Partners XII-A, L.P. ("USVP XII-A", and together with USVP XII, the "USVP XII Funds"), and (iii) 921,131 shares of Common Stock held directly by U.S. Venture Partners Select Fund I, L.P. ("USVP SFI"), on its own behalf and as nominee for U.S. Venture Partners Select Fund I-A, L.P. ("USVP SFI-A"). PMG XII is the general partner of each of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C ("PMG SFI", and together with USVP XII and USVP XII-A, USVP SFI, USVP SFI-A, and PMG XII, the "U.S. Venture Partners") is the general partner of USVP SFI and USVP SFI-A. Dr. Jonathan Root, Steven Krausz, Richard Lewis and Dafina Toncheva are the managing members of PMG XII, who may be deemed to share voting and dispositive power over the shares held by the USVP XII Funds. In addition, Casey M. Tansey, a member of the Issuer's board of directors, is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein. The amount beneficially owned by each Reporting Person is determined based on 20,601,684 shares of Common Stock outstanding as of November 5, 2025 as reported by the Issuer in its Form 10-Q.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of (i) 1,686,403 shares of Common Stock held directly by USVP XII, (ii) 85,587 shares of Common Stock held directly by USVP XII-A and (iii) 921,131 shares of Common Stock held directly by U.S. Venture Partners USVP SFI, on its own behalf and as nominee for USVP SFI-A. PMG XII is the general partner of each of USVP XII and USVP XII-A. PMG SFI is the general partner of USVP SFI and USVP SFI-A. Dr. Jonathan Root, Steven Krausz, Richard Lewis and Dafina Toncheva are the managing members of PMG XII, who may be deemed to share voting and dispositive power over the shares held by the USVP XII Funds. In addition, Casey M. Tansey, a member of the Issuer's board of directors, is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein. The amount beneficially owned by each Reporting Person is determined based on 20,601,684 shares of Common Stock outstanding as of November 5, 2025 as reported by the Issuer in its Form 10-Q.


SCHEDULE 13G



U.S. Venture Partners XII, L.P.
Signature:/s/ Dale Holladay
Name/Title:Dale Holladay, Attorney-in-Fact
Date:11/14/2025
Presidio Management Group XII, L.L.C.
Signature:/s/ Dale Holladay
Name/Title:Dale Holladay, Attorney-in-Fact
Date:11/14/2025
Casey M. Tansey
Signature:/s/ Dale Holladay
Name/Title:Dale Holladay, Attorney-in-Fact
Date:11/14/2025

FAQ

What stake did U.S. Venture Partners report in SI on Schedule 13G?

U.S. Venture Partners XII, L.P. reported 1,686,403 shares, representing 8.2%, with shared voting and dispositive power.

How much of SI does Presidio Management Group XII, L.L.C. report owning?

Presidio Management Group XII, L.L.C. reported 2,693,121 shares, or 13.1%, with shared voting and dispositive power.

What is Casey M. Tansey’s reported beneficial ownership in SI?

Casey M. Tansey reported 2,740,787 shares (13.3%), including 47,666 with sole power and 2,693,121 with shared power.

What share count did the filers use to calculate ownership percentages for SI?

Percentages are based on 20,601,684 shares outstanding as of November 5, 2025, per the company’s Form 10-Q.

What is the event date for this beneficial ownership report on SI?

The date of the event requiring the filing is 09/30/2025.

What class of securities is covered in the SI Schedule 13G?

The filing covers Common Stock, par value $0.001 per share (CUSIP 82537J108).
Shoulder Innovations, Inc.

NYSE:SI

View SI Stock Overview

SI Rankings

SI Latest News

SI Latest SEC Filings

SI Stock Data

288.63M
18.41M
Commercial Banking
Surgical & Medical Instruments & Apparatus
US
GRAND RAPIDS